Evidence map›Paper›PMID 33151316›Full record

ArticleJAMA network open2020

Trends in Positive BRCA Test Results Among Older Women in the United States, 2008-2018.

Fangjian Guo, Matthew Scholl, Erika L Fuchs, Rebeca Wong, Yong-Fang Kuo, Abbey B Berenson

Open access · goldAbstract read
In one paragraph

Article in JAMA network open, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.9field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Fangjian GuoDepartment of Obstetrics and Gynecology, The University of Texas Medical Branch at Galveston, Galveston.
Matthew SchollSchool of Medicine, The University of Texas Medical Branch at Galveston, Galveston.
Erika L FuchsDepartment of Obstetrics and Gynecology, The University of Texas Medical Branch at Galveston, Galveston.
Rebeca WongCenter for Interdisciplinary Research in Women's Health, The University of Texas Medical Branch at Galveston, Galveston.
Yong-Fang KuoCenter for Interdisciplinary Research in Women's Health, The University of Texas Medical Branch at Galveston, Galveston.
Abbey B BerensonDepartment of Obstetrics and Gynecology, The University of Texas Medical Branch at Galveston, Galveston.
The University of Texas Medical Branch at Galveston · US

Funding

UTMB WOMEN'S HEALTH RESEARCH SCHOLARS PROGRAMK12HD052023 · NICHD · UNIVERSITY OF TEXAS MEDICAL BR GALVESTON · PI BERENSON, ABBEY B · 2005 to 2023
$8.1M
Genetic testing in young women for cancer preventionK07CA222343 · NCI · UNIVERSITY OF TEXAS MED BR GALVESTON · PI GUO, FANGJIAN · 2018 to 2022
$632k
NCI NIH HHS K07 CA222343NICHD NIH HHS K12 HD052023
6 · The paper itself

Abstract

Importance: Genetic testing for BRCA1/2 pathogenic variants has been used for targeted, individualized cancer prevention and treatment. A positive BRCA test result indicates a higher risk for developing BRCA-related cancers. During the past decade, testing criteria have loosened. The impact of these loosened criteria on BRCA testing in older women has not previously been studied. Objective: To assess whether the rate of positive BRCA test results changed between 2008 and 2018 among older women in the United States. Design, Setting, and Participants: This cross-sectional study used a 10% random sample of women 65 years of age or older from Optum's deidentified Integrated Claims-Clinical data set (2008-2018), a large national electronic health record data set. A total of 5533 women with BRCA test results from January 1, 2008, to March 31, 2018, were evaluated. Main Outcomes and Measures: Annual percentage change in positive BRCA test results was evaluated. Multivariable logistic regression models were used to assess the association between positive test results and race/ethnicity, region of residence, income, educational level, and personal history of breast or ovarian cancer. Results: Of 5533 women 65 years of age or older (mean age, 68.1 years [95% CI, 67.9-68.4 years]) who underwent BRCA testing from 2008 to 2018, most (4679 [84.6%]) were non-Hispanic White women, and 1915 (34.6%) resided in the Midwest. Positive BRCA test results decreased from 85.7% (36 of 42) in 2008 to 55.6% (140 of 252) in 2018 (annual percentage change, -2.55; 95% CI, -3.45 to -1.64). Among patients with breast or ovarian cancer, positive test results decreased from 83.3% (20 of 24) in 2008 to 61.6% (61 of 99) in 2018, while among women without breast or ovarian cancer, positive test results decreased from 87.5% (21 of 24) in 2008 to 48.4% (74 of 153) in 2018 (annual percentage change, -3.17 vs -2.49; P = .29). Women with positive test results were more likely to be non-Hispanic Black women, to live in the West or South, to live in areas with a low percentage of college graduates, or to not have a personal history of breast or ovarian cancer. Conclusions and Relevance: This study suggests that there was a significantly decreasing rate of positive BRCA test results among women 65 years of age or older. Socioeconomic and regional disparities in testing use remain an issue.

Indexed as

AgedBlack or African AmericanBRCA1 ProteinBreast NeoplasmsCross-Sectional StudiesEarly Detection of CancerFemaleGenetic TestingHumansOvarian NeoplasmsUnited StatesWhite PeopleBRCA1 ProteinBRCA1 protein, human

Identifiers

PMID33151316
PMCPMC7645697
OpenAlexW3096986961

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.